MwanzoMEHCQ • OTCMKTS
add
23andMe Holding Co.
Bei iliyotangulia
$ 1.17
Bei za siku
$ 1.07 - $ 1.18
Bei za mwaka
$ 0.48 - $ 12.76
Thamani ya kampuni katika soko
30.85M USD
Wastani wa hisa zilizouzwa
8.09M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
OTCMKTS
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 60.26M | 34.67% |
Matumizi ya uendeshaji wa biashara | 65.06M | -22.18% |
Mapato halisi | -53.04M | 80.92% |
Kiwango cha faida halisi | -88.01 | 85.83% |
Mapato kwa kila hisa | — | — |
EBITDA | -21.80M | 62.70% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 79.35M | -67.27% |
Jumla ya mali | 277.42M | -54.39% |
Jumla ya dhima | 214.70M | -7.06% |
Jumla ya hisa | 62.72M | — |
hisa zilizosalia | 26.83M | — |
Uwiano wa bei na thamani | 0.50 | — |
Faida inayotokana na mali | -21.15% | — |
Faida inayotokana mtaji | -42.49% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -53.04M | 80.92% |
Pesa kutokana na shughuli | -44.65M | -270.23% |
Pesa kutokana na uwekezaji | elfu 887.00 | 144.09% |
Pesa kutokana na ufadhili | elfu -19.00 | -118.10% |
Mabadiliko halisi ya pesa taslimu | -43.79M | -213.47% |
Mtiririko huru wa pesa | -20.18M | -469.10% |
Kuhusu
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Ilianzishwa
Apr 2006
Makao Makuu
Tovuti
Wafanyakazi
571
